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ABSTRACT
Metabolic syndrome (MS) is a disorder comprising central obesity, dyslipidemia, raised blood pressure, in-
sulin resistance. The aim of the present study was to develop a cheap, easy and reproducible rat model of MS. 
36 male Wistar rats were divided in 3 groups: a control group (C) receiving regular rat chow diet, a high-fat 
(HF) group receiving lard enriched rat chow and a high-fat high-fructose (HFHF) group receiving lard and 
fructose enriched rat chow. HF and HFHF groups had also 10% fructose in their drinking water. The du-
ration of the study was 8 weeks. Body weights were measured weekly. At the end of the study insulin toler-
ance test (ITT) was performed. Liver and fat weight index were measured after sacrifice. Lipid biochemical 
parameters and insulin concentration in serum were determined. Liver triglycerides (TG) were measured. 
The oxidative stress in serum was assessed by thiobarbituric reactive substances (TBARS). At the end of the 
study the animals did not differ in their body weights across the groups, but the fat index in both HF and 
HFHF groups was higher. Plasma TG and cholesterol were raised in both groups and the ratio cholesterol/
HDL-cholesterol was higher. Liver TG were elevated in HFHF rats. ITT revealed reduced insulin sensitivi-
ty in both experimental groups although serum insulin was elevated only in HFHF group. TBARS were in-
creased in both HF and HFHF groups. Both models displayed most of the features of MS; the HFHF proba-
bly better reflects the ‘cafeteria’ diet and its unhealthy consequences.
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INTRODUCTION 
The metabolic syndrome (MS) is a condition 
of impaired energy metabolism. About 25% of the 
adults worldwide suffer MS according to the Inter-
national Diabetes Federation (IDF) (1). The most sig-
nificant factors for the development of MS are con-
sidered insulin resistance (the DECODE study) (2) 
and the visceral obesity (3). IDF defines MS as a con-
dition including visceral obesity and at least two of 
the following: high triglycerides, low HDL-cholester-
ol, high blood pressure, and fasting hyperglycemia as 
a result of insulin resistance (1). 
The experimental models of MS are valuable 
tools in the study of its pathogenesis, prevention and 
therapy. There are many such models in rodents and 
other experimental animals, but no one has been 
universally accepted. Since non-rational nutrition 
with high caloric intake is considered one of the lead-
ing causes for MS in humans (4), the animal models 
frequently rely on manipulating the dietary intake. 
The diets used to develop models of MS contain high 
amounts of carbohydrates, fats or both. Fructose is 
the preferred monosaccharide, included in the ani-
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mal food or drinking water. One of the most popu-
lar models is the one with 10% fructose solution as a 
drinking water given over several weeks (5,6,7). An-
other approach is to add different fats to the food. 
Animal fats turn out to be more effective to produce 
signs of MS compared to plant-derived fats (8,9). 
Lard or beef fat are usually used. The mixed models 
utilizing both animal fats rich in saturated fatty acids 
and fructose are considered most relevant to the MS 
in men (10,11,12,13).
THE AIM of the present study was to develop 
an easy, cheap and reproducible experimental model 
of MS, displaying most of the characteristic features 
of the condition in men. We have studied and char-
acterized two models of MS in rats with increased 
content of simple carbohydrates and fats in their diet, 
given in different ratios. 
MATERIALS AND METHODS
Experimental animals
The study has been performed on 36 male Wi-
star rats. The animals were kept at an ambient tem-
perature of 20-25 °C, 12-hour light-dark cycle and 
free access to food and water. The study has been 
approved by the Commission of foods safety in the 
Ministry of Agriculture and Foods. 
The experimental animals were allocated in 3 
groups of 12 rats each, with initial body weight rang-
ing between 204 and 232 g (on the average, 219-220 
g in each group). The duration of the study was 8 
weeks. The groups were as follows: a control group 
(C), a group fed high fat (HF) diet and a group fed 
high fat and high fructose (HFHF) diet.
Diets
The rats from the control group were fed by 
the standard rat chow and were given plain water to 
drink. With each 100 g food consumed, the animals 
from this group had a caloric intake of 279 kcal.
The rats from the HF group had a diet rich in 
lard (20%) and drank 10% fructose solution. In this 
way HF group had a caloric intake of 403 kcal per 
100g food, of which 45 % was coming from the fat 
added. These rats also consumed 10% fructose in the 
drinking water, allowing additional 40 kcal per 100 
ml water consumed.
The rats from the third group (HFHF) were giv-
en a diet with lard (17%) and fructose (17%) added to 
the standard rat chow together with 10% of fructose 
in the drinking water. The caloric intake was 405 
kcal per 100 g food, of which 38% was provided by 
the lard and 17% by the fructose added to the stan-
dard rat chow. These animals had also additional 40 
kcal per 100 ml 10% fructose solution consumed. 
The food and fluids consumption was mea-
sured daily. The body weight was taken once weekly. 
Insulin tolerance test (ITT)
After 8 weeks of a diet load an insulin tolerance 
test was carried out. The animals were injected i.p. 
with regular insulin (ActRapid), dissolved in saline, 
at a dose of 0.75 UI/kg. Blood sugar was measured by 
a glucometer (ACCU-CHEK Performa). Blood sam-
ples were taken by incision of the distal part of the 
tail (14) immediately before the injection of insulin 
(at time 0) and at the 30th, 60th and 90th minute. Blood 
was taken from non-fasted animals. 
At the end of the experimental period blood 
was taken from the sublingual veins of the animals 
under ether anesthesia. The blood was centrifuged 
and the serum was refrigerated at -20˚C until bio-
chemically tested. 
After euthanasia of the rats the livers and the 
right retroperitoneal fat pads were dissected on ice, 
measured and the corresponding organ indices cal-
culated (as a ratio to the body weight x 103). A part of 
the liver was stored at -20°C for biochemical testing.
Biochemical tests
Serum triglycerides (TG), cholesterol and HDL-
cholesterol were measured by using colorimetric kits 
of HUMAN, at a spectrophotometer AURIUS 2021 
(Cecil Instruments Ltd.). TGs in the liver were de-
termined in 10% tissue homogenates in TRIS buf-
fer. The atherogenic ratios cholesterol/HDL-choles-
terol and TG/HDL-cholesterol were also calculated 
(15,16). 
The levels of serum insulin were measured by 
ELISA (Rat Insulin ELISA Kit of Shibayagi Co., Ltd.). 
As markers of oxidative stress in serum, sub-
stances reacting with thiobarbituric acid (TBARS) 
were measured by a colorimetric method (17) with 
malondialdehyde as a standard. 
Statistics 
Results are presented as a mean ± standard er-
ror of the mean (SEM). Two groups were compared 
by Student’s t-test. Differences were considered sig-
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nificant at p<0.05. The statistical software GraphPad 
Prism 5 was used (GraphPad Software, Inc.). 
RESULTS 
Experimental groups consumed significantly 
less food than the control animals and HFHF ani-
mals consumed more food than HF animals. At the 
same time experimental groups consumed more flu-
ids than the control group and the HFHF animals 
also drank more 10% fructose compared to the HF 
group. All groups differed in their total daily caloric 
intake from food and drinking water (Table 1).
At the end of the study body weight of the ani-
mals did not differ among groups. There was no dif-
ference between groups in respect to liver weights 
and liver index. The retroperitoneal fat was signifi-
cantly increased in HF and HFHF groups compared 
to controls. Biological parameters are presented on 
Table 1.
The ITT showed impaired response to insulin 
in both HF and HFHF group. The results are pre-
sented on Fig. 1 and Table 2.
The level of serum insulin was elevated in the 
group HFHF (Fig. 2). 
Serum lipids
TGs and cholesterol in serum were increased 
in both dietary manipulated groups compared to the 
control. HDL-cholesterol showed no change. Lip-
id profile is presented on Fig. 3. Atherogenic indices 
were higher in rats from the HF and HFHF groups 
(Fig. 4).
The liver TGs were increased in HFHF relative 
to the control and HF groups (Fig. 5).
Fig. 1. Insulin tolerance test
C HF HFHF
Food intake (g/day/group) 149.2±1.42 89.97±1.75*** 91.86±1.67***#
Fluid intake (ml/day/group) 199.3±2.38 240±3.31*** 273.2±5.56***###
Caloric intake (kcal/day/group) 416.9±3.92 446.4±6.97*** 481.2±5.89***###
Initial body weight (g) 219.2±2.14 220±1.23 219.5±2.12
Final body weight (g) 348.8±8.35 351.5±8.75 360.8±6.34
Liver weight (g) 14.16±0.69 15.22±0.85 15.26±0.41
Liver index 4.03±0.14 4.2±0.15 4.18±0.14
Fat weight (g) 2.31±0.26 4.43±0.45** 5.51±0.75**
Fat index 6.61±0.75 12.18±1.04** 15±1.85**
Table 1. Biological parameters of rats from the control (C), high fat (HF) and high fat high fructose (HFHF) group; ** 
p<0.01, *** p<0.001 vs C; # p<0.05, ### p<0.001 vs HF
Fig. 2. Serum insulin levels
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The serum concentration of TBARS was in-
creased relative to control rats in both HF and HFHF 
groups (Fig. 6).
DISCUSSION 
The experimental models of MS aim at repro-
ducing most of the characteristic features of the syn-
  Fig. 3. Serum lipid profile
Fig. 4. Atherogenic indices
30 min 60 min 90 min
mmol/L % of initial value mmol/L % of initial value mmol/L % of initial value
C 3.64 ± 0.12 53.56 ± 1.76 3.46 ± 0.11 50.89 ± 1.81 3.74 ± 0.15 55.22 ± 2.48
HF 4.31 ± 0.23 71.3 ± 3.11*** 3.77 ± 0.17 63.22 ± 2.41*** 3.93 ± 0.27 66.56 ± 4.87
HFHF 4.22 ± 0.17* 65.73 ± 2.75** 4.18 ± 0.15** 65.45 ± 3.13** 4.37 ± 0.19* 68.2 ± 2.92**
Table 2. Plasma glucose concentration in insulin tolerance test (ITT) in rats from the control (C), high fat (HF) and high 
fat high fructose (HFHF) group; * p<0.05, ** p < 0.01, *** p < 0.001 vs C
Fig. 5. Liver triglycerides Fig. 6. Concentration of TBARSs in serum
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drome in humans, such as overweight, visceral obesi-
ty, dyslipidemia, insulin resistance, impaired glucose 
tolerance, hypertension, etc. 
Different models of MS have been described in 
the literature – genetic or diet-induced. The last are 
considered as better reflecting the condition in men, 
since it is the result mainly of the so called ‘Western’ 
pattern of feeding, characterized by the intake of ani-
mal fat high in saturated fatty acids, and fructose as a 
widely used sweetener, particularly in the form of the 
glucose-fructose syrup. 
Weight gain is one of the typical features of 
MS. Dietary manipulations on experimental ani-
mals however, do not always lead to increase in body 
weight and in this respect the results in the literature 
vary widely. In our experimental setting, similarly to 
Nagai (18), Ai (19) and others, the final body weight 
did not differ between control and dietary manipu-
lated groups. A possible explanation of this finding is 
the fact that experimental groups consumed less of 
the food enriched in fat and fructose, probably due to 
the higher caloric intake with these diets. 
The central abdominal obesity is an important 
symptom of MS. To evaluate this parameter in the 
present study the retroperitoneal fat pad has been 
used as a component of the visceral adiposity. The 
fat cell store around the kidney was significantly in-
creased in both diets. The absolute sizes of this ad-
ipose tissue as well as its ratios relative to the body 
weights (the fat index) are more than twice larger in 
the experimental groups compared to the control 
one. Similar results are reported for all the fat visceral 
localizations in the dietary models of MS (18,19,20).
Dyslipidemia in MS is typically a combination 
of lipid changes comprising mainly high TG levels 
and low HDL-cholesterol. While overt hypercholes-
terolemia is not characteristic, changes are usually 
found in the LDL-cholesterol fractions with the in-
crease of the small dense particles known to be more 
atherogenic.
In experimental models of MS the dyslipidemia 
is usually presented by high levels of TG. In our ex-
periments the groups HF and HFHF had both signif-
icant increase in TG more than 2 and 3 times, respec-
tively, compared to controls. Though these groups 
did not differ between each other, the higher levels in 
HFHF rats can be linked to the well documented lip-
ogenic effect of fructose (20,21,18,22). 
Dietary models of MS in rats published in lit-
erature vary significantly in respect to the levels of 
total and LDL-cholesterol. In some cases these lip-
id parameters are elevated – e.g. in diets rich in fruc-
tose (12), or in diets rich in fat and fructose (21, 23). In 
others, no changes are reported in analogous experi-
mental settings (20). In our models we have definite-
ly increased levels of total cholesterol in both dietary 
manipulated groups. 
The changes reported for HDL-cholesterol also 
vary widely, with predominance of the negative re-
sults. De Castro et al. (12) found decrease of HDL-
cholesterol only in young rats (age of 4 weeks), but 
not in older animals (age of 12 weeks). Our results 
are in agreement with these data in respect to older 
rats, since our animals are in the same age range. In-
terestingly, in a former study of ours, where MS was 
induced by only 10% fructose in the drinking water, 
we found low levels of HDL and normal total cho-
lesterol. This could be interpreted as an indication 
that in the present experiment the lack of change in 
HDL-cholesterol might be caused by the high total 
cholesterol. 
The atherogenic indices TG/HDL-cholesterol 
and total cholesterol/HDL-cholesterol were also high 
in our dietary groups. These indices are used in clin-
ical medicine in estimating cardiovascular risk of pa-
tients (15,16). In the presence of other risk factors in 
experimental conditions, these could possibly be uti-
lized also in a model of cardiovascular pathology. 
Insulin resistance as a basic characteristic of MS 
can be studied in experimental conditions by differ-
ent methods. Insulin-tolerance test is frequently uti-
lized for this purpose (8,19). It can reveal the im-
paired response to insulin due to decreased sensitiv-
ity of insulin receptors. In our experimental setting 
rats from both dietary manipulated groups had de-
creased effects of insulin as reflected by the higher 
glucose blood levels, measured at the three 30 minute 
intervals during an hour and a half. Although signif-
icantly different from the control group, the levels of 
blood sugar did not differ between the two experi-
mental groups. 
Another index of insulin resistance – hyperin-
sulinemia, was found only in the group of animals 
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receiving food enriched in lard and fructose. This 
fact renders the corresponding model (HFHF) closer 
to the MS in humans, where the insulin resistance is 
compensated by higher levels of insulin. The negative 
results in the rats fed with only lard-enriched food 
could be explained with the lower amount of fruc-
tose that they were taking. It is known that dietary 
fructose, when in excess, can contribute via different 
mechanisms to insulin resistance and other metabol-
ic disturbances in MS (22). The high consumption of 
saturated fatty acids is associated with decreased sen-
sitivity to insulin (19,24,25), but according to some 
authors (26), feeding with animal fats results in insu-
lin resistance only under conditions of hypercaloric 
intake. 
MS is frequently manifested clinically by non-
alcoholic fatty liver disease (27). Many of the experi-
mental models of MS are also associated with chang-
es in liver that are similar to hepatic steatosis. Such 
findings have been reported as a result of feeding an-
imals with fat-enriched diet (8,13), or with diet com-
bining fat and carbohydrates (12,28), as well as fruc-
tose-treated rats (7,22). In our experiment liver TG 
were elevated significantly in the HFHF group com-
pared to the control one.
Although MS is mainly a metabolic disorder, 
this condition can be regarded also as a state of oxi-
dative stress (29,30). It has been even defined by some 
authors a component of MS (31). In general oxidative 
stress occurs when the production of reactive oxygen 
species surpasses the antioxidant capacity of the bi-
ological system. In MS and diabetes type 2 it is not 
only the high blood glucose that contributes to the 
generation of free radicals, but the free fatty acids are 
also involved. On its turn, oxidative stress appears 
to be a critical mechanism for the glucotoxicity, in-
ducing both cellular insulin resistance and injury to 
beta cells (32). Markers of oxidative stress have been 
shown to be increased in many experimental mod-
els of MS (5,7,13,23). In fructose rich diet oxidative 
stress has been manifested also by reduced antioxi-
dant defense (33). In our models of MS we measured 
plasma TBARS as a marker of lipid peroxidation and 
found a significant increase in both HF and HFHF 
rats, showing that with the two dietary approaches 
oxidative stress is present.  
CONCLUSION 
In the present study of experimental MS we uti-
lized two similar dietary approaches by loading the 
normal rat chow and drinking water with different 
ratios of animal fat (lard) and simple carbohydrate 
(fructose). Unlike most of the models, described in 
the literature, we used relatively small amounts of 
these additives, aiming to mimic closely the ‚cafe-
teria diet‘, typical for the unhealthy nutritional hab-
its of Western culture. Nevertheless, these diets were 
associated with significantly higher caloric intake. 
Both models that we studied reproduced most of the 
metabolic features of MS in humans – visceral obe-
sity, dyslipidemia, insulin resistance as measured by 
the ITT. Markers of oxidative stress were elevated in 
the two experimental groups. HFHF group present-
ed evidence of changes resembling the non-alcoholic 
fatty liver disease – higher TG hepatic content. 
Indeed, with most of the parameters studied, 
the effects of both diets were similar. Yet, HFHF diet 
produced more pronounced changes. In addition, se-
rum level of insulin was found to be increased only 
in the HFHF group, as were the liver TG levels. The 
advantages, manifested by the HFHF model, though 
small, made us consider that the dietary manipula-
tion with animal fat and fructose added to the food 
of rats together with 10% fructose in the drinking 
water, is the preferred option for a model of MS in 
these animals. Based on these results, we can con-
clude that this model can be given priority in experi-
mental studies of MS. 
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